Self-Compassion and Psychological Health of Parents: A Meta-Analysis Focused on Some Neurodevelopmental Disorders.

J Autism Dev DisordApr 21, 2025 (epub)
Clinical ResearchPsychiatryPediatricsOpen access

Cansu Ozturk, H Senay Guzel

✦ AI-curated · Sources linked

In 30 seconds

This random-effects meta-analysis examined quantitative studies of self-compassion and psychological health among parents of children with neurodevelopmental disorders (NDDs). Of 131 records identified, 15 studies met the inclusion criteria. Self-compassion had large, negative associations with parental depression and parenting stress, a moderate, negative association with parental anxiety, and a large, positive association with parental well-being. The findings describe relationships rather than evidence that increasing self-compassion causes improved psychological health.

Key findings

  • Self-compassion was associated with lower parental depression and parenting stress; both relationships were described as large, negative, and significant.
  • The association between self-compassion and parental anxiety was moderate, negative, and significant.
  • Self-compassion had a large, positive, and significant association with parental well-being.

Why it matters

Parents of children with NDDs may experience psychological distress and parenting stress. The pooled findings link self-compassion with several aspects of parental psychological health, suggesting it may be relevant when assessing parental well-being. Because the evidence concerns associations, it does not establish that self-compassion interventions will reduce distress or stress.

What to keep in mind

The meta-analysis included 15 quantitative studies, and the reported associations do not establish causality.

Source

Published in J Autism Dev Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.